‘Promising’ Medicago COVID-19 vaccine moves to Phase 2/3 trials

111820_vaccine.png
Photo: Medicago website

Medicago CEO Bruce Clark is pleased with the progress of the company’s vaccine.

The quest for a coronavirus vaccine has moved from “if” to “when,” with a Quebec City-based company announcing “very promising results” in Phase 1 clinical trials.